Literature DB >> 29468543

Detection of Retinoblastoma Protein Phosphorylation by Immunoblot Analysis.

Pedro G Santiago-Cardona1, Jaileene Pérez-Morales2, Jonathan González-Flores2.   

Abstract

The retinoblastoma tumor suppressor protein (pRb) is a preeminent tumor suppressor that acts as a cell cycle repressor, specifically as an inhibitor of the G1-S transition of the cell cycle . pRb is a phosphoprotein whose function is repressed by extensive phosphorylation in several key residues, and therefore, pRb's phosphorylation status has become a surrogate for pRb activity. In particular, hyperphosphorylation of pRb has been associated with pathological states such as cancer, and therefore, assessing pRb's phosphorylation status is increasingly gaining diagnostic and prognostic value, may be used to inform therapeutic decisions, and is also an important tool for the cancer biologists seeking an understanding of the molecular etiology of cancer. In this chapter, we discuss an immunoblot protocol to detect pRb phosphorylation in two residues, serine 612 and threonine 821, in protein extracts from cancer cells.

Entities:  

Keywords:  Cell cycle control; Immunoblot; Lung adenocarcinoma; Oncogenesis; Phosphorylation; Retinoblastoma protein

Mesh:

Substances:

Year:  2018        PMID: 29468543      PMCID: PMC6613207          DOI: 10.1007/978-1-4939-7565-5_6

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  2 in total

1.  Immunoblot Validation of Phospho-Specific Antibodies Using Lung Cancer Cell Lines.

Authors:  Wilfredo M Pedreira-García; Jaileene Pérez-Morales; Camille Chardón-Colón; Jennifer Cabán-Rivera; Pedro G Santiago-Cardona
Journal:  Methods Mol Biol       Date:  2021

2.  Hyper-phosphorylation of Rb S249 together with CDK5R2/p39 overexpression are associated with impaired cell adhesion and epithelial-to-mesenchymal transition: Implications as a potential lung cancer grading and staging biomarker.

Authors:  Jaileene Pérez-Morales; Darielys Mejías-Morales; Stephanie Rivera-Rivera; Jonathan González-Flores; Mónica González-Loperena; Fernando Y Cordero-Báez; Wilfredo M Pedreira-García; Camille Chardón-Colón; Jennifer Cabán-Rivera; W Douglas Cress; Edna R Gordian; Teresita Muñoz-Antonia; Mauricio Cabrera-Ríos; Angel Isidro; Domenico Coppola; Marilin Rosa; Theresa A Boyle; Victoria Izumi; John M Koomen; Pedro G Santiago-Cardona
Journal:  PLoS One       Date:  2018-11-19       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.